about
Epidemiological characteristics of human prion diseasesImproving platelet transfusion safety: biomedical and technical considerationsSilent Prions and Covert Prion TransmissionAnalysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease PrionsHuman prion diseases: surgical lessons learned from iatrogenic prion transmissionAdvanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease.Recent US Case of Variant Creutzfeldt-Jakob Disease-Global Implications.Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.Overview and evaluation of 15 years of Creutzfeldt-Jakob disease surveillance in Belgium, 1998-2012.Rapid and Highly Sensitive Detection of Variant Creutzfeldt-Jakob Disease Abnormal Prion Protein on Steel Surfaces by Protein Misfolding Cyclic Amplification: Application to Prion Decontamination Studies.Increased Abundance of M Cells in the Gut Epithelium Dramatically Enhances Oral Prion Disease SusceptibilityThe influence of PRNP polymorphisms on human prion disease susceptibility: an update.Prion disease pathogenesis in the absence of the commensal microbiota.A case cluster of variant Creutzfeldt-Jakob disease linked to the Kingdom of Saudi Arabia.Developing Therapeutics for PrP Prion Diseases.Infectious Agents in Bovine Red Meat and Milk and Their Potential Role in Cancer and Other Chronic Diseases.Variant Creutzfeldt-Jakob disease deferral in Canada: impact of stop dates.The Risk of Prion Infection through Bovine Grafting Materials.A prion reduction filter does not completely remove endogenous prion infectivity from sheep blood.Prion Diagnosis: Application of Real-Time Quaking-Induced Conversion.How do PrPSc Prions Spread between Host Species, and within Hosts?Public health risks from subclinical variant CJD.Food safety challenges and One Health within Europe.Recombinant PrPSc shares structural features with brain-derived PrPSc: Insights from limited proteolysis.Prion Diseases.Generation of novel neuroinvasive prions following intravenous challenge.Creutzfeldt-Jakob disease mortality in Canada, 1998 to 2013.Oral Prion Neuroinvasion Occurs Independently of PrP Expression in the Gut Epithelium
P2860
Q26744136-3032A333-41A5-4957-9202-0AA5473F427DQ26775408-73044629-F2E0-42FE-9060-A1003CB4B9FEQ26776368-FDE147FF-E666-4A28-996B-3C650963DC37Q28831096-4E004900-E531-42A0-91CF-9150AC8C096EQ30249207-F1956786-0DCB-4161-B978-1AD4D1888BB3Q31095751-65AD66DE-DAEC-4F21-9E36-2BC64734E94FQ35546137-5E5C87DB-425A-47CB-ADC0-32C4B0F63357Q35775559-33661049-4C6A-4BE3-ABCE-8BC1DC9378F0Q35859408-033EB877-D628-407B-AE41-BC38E4C34D2FQ35901624-F30801E3-65D5-42A7-B3FD-955F0DEA6ADBQ36223774-1CEBCF69-2C62-4BF7-AA4E-17BC3434A03FQ38507000-CD934C53-27C9-47FA-B860-E94F5E0BAF6FQ38679276-6708234B-86D9-4FE5-BC01-F595B2C8416DQ38817451-E0867C58-0729-4A5E-8EBC-B42CEB63D53EQ39092621-04ADB49B-7E04-44E7-ACEA-606D4755EAAFQ39204170-0B086E0F-3894-4D1F-A23D-4A57F1BE7140Q40354458-D514904E-5E0A-44D6-AE3A-DC0C6C5D5846Q40800092-2B1EA366-D9AC-4E41-B488-784E4388DBCBQ41191548-AE24ACC6-020D-46C2-B0A0-B67550058A89Q43050312-4709AE2E-8984-4704-90B6-847D51A0FEC9Q46251829-8B425806-BD2F-4E66-89AB-7EE51B7A1B22Q47130009-F77302CD-BCD3-4472-8643-F497851675E7Q47136328-41B40732-6ED3-4088-9F75-86251ED26D1CQ47829166-35CC76DC-C1B0-4EB9-8804-A1C6C1B1D045Q50908801-64AAC261-FB98-405D-B525-DA0B9BC67D9FQ51736170-40BE0FDA-4F92-487D-B7B9-4C5FC747FC40Q55181609-EF1E5C42-69C5-4E24-9C22-A2E861EA637CQ58746084-6D4447FA-2934-498C-88CF-C5F2AA6C8A7E
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Variant CJD. 18 years of research and surveillance.
@ast
Variant CJD. 18 years of research and surveillance.
@en
Variant CJD. 18 years of research and surveillance.
@nl
type
label
Variant CJD. 18 years of research and surveillance.
@ast
Variant CJD. 18 years of research and surveillance.
@en
Variant CJD. 18 years of research and surveillance.
@nl
prefLabel
Variant CJD. 18 years of research and surveillance.
@ast
Variant CJD. 18 years of research and surveillance.
@en
Variant CJD. 18 years of research and surveillance.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Variant CJD. 18 years of research and surveillance.
@en
P2093
Abigail B Diack
Aileen Boyle
Richard Knight
Robert G Will
Sandra McCutcheon
P2860
P304
P356
10.4161/PRI.29237
P5008
P577
2014-11-01T00:00:00Z